However, in PRP patients without CARD14 mutations, NF-κB is also activated through IL-1ß signaling, resulting in upregulation of CCL20 expression and subsequent activation of TH17 cells (12). The gene discussed is NFKB1; the disease is familial pityriasis rubra pilaris.